Skip to Content


Active Substance: hepatitis B, recombinant surface antigen
Common Name: triple antigen hepatitis B vaccine (recombinant)
ATC Code: J07BC
Marketing Authorisation Holder: Evans Vaccines Ltd.
Active Substance: hepatitis B, recombinant surface antigen
Status: Withdrawn
Authorisation Date: 2000-08-04
Therapeutic Area: Hepatitis B Immunization
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

This vaccine is indicated for active immunisation against hepatitis B virus infection in non-immune adults (>=18 years). The specific at risk categories to be immunised are to be determined on the basis of official recommendations.

The marketing authorisation for Hepacare has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.